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Abstract : Various methods, devices, and techniques have been developed to 
improve safety during laparoscopic hepatectomy procedures.  Among these, the 
Pringle maneuver （PM） is widely used to minimize blood loss during liver tran-
sections ; however, the risk of ischemic injury associated with this technique is 
increased by poor hepatic reserve and regeneration dysfunction secondary to liver 
cirrhosis.  This retrospective study evaluated the short-term outcomes and feasibil-
ity of precoagulation for endoscopic hepatectomy without PM in patients with 
liver cirrhosis.  Eleven patients with liver cirrhosis who also underwent endoscopic 
hepatectomy for hepatocellular carcinoma were recruited to undergo either micro-
wave tissue coagulation or radiofrequency ablation for precoagulation before liver 
transection.  A wedge resection without the PM was performed in all patients, with 
seven patients selected for bipolar radiofrequency ablation and four patients for 
microwave coagulation therapy.  The procedures included video-assisted thoraco-
scopic hepatectomy in two patients and laparoscopic hepatectomy in nine patients.  
One patient who underwent radiofrequency ablation developed postoperative bleed-
ing （Clavien-Dindo grade Ⅲ）.  In conclusion, precoagulation can help to minimize 
intraoperative blood loss without the PM, contributing to effective resection of liver 
tumors.  We propose that precoagulation could serve as a standard technique for 
endoscopic hepatectomy in patients with cirrhosis.
Key words : laparoscopic hepatectomy, thoracoscopic hepatectomy, precoagulation, liver 
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Introduction
　Blood loss during hepatectomy necessitating perioperative blood transfusion has a direct 
negative effect on the postoperative course and oncological outcome of patients 1，2）.  Multiple 
reports support the feasibility, safety, and benefits of laparoscopic over open hepatectomy 3-10）. 
Furthermore, laparoscopic hepatectomy （LH） was recently suggested as feasible even in patients 
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with cirrhosis 3，9）; however, transection of cirrhotic liver parenchyma is technically difcult, and 
increased bleeding can occur secondary to brosis, portal hypertension, and coagulopathy.  Conse-
quently, a standard method of LH in patients with cirrhosis has not been established.
　The Pringle maneuver （PM） is widely used to minimize blood loss during liver transection. 
Liver ischemia-reperfusion, wherein many inammatory cytokines are produced due to an increased 
warm ischemia time, can induce injury in liver cells and hepatic sinusoidal endothelial cells 11）, and 
cirrhotic liver tissue is especially susceptible to ischemia-reperfusion injury 12）.  Therefore, if it is 
possible to safely transect cirrhotic liver parenchyma with poor hepatic reserve and regeneration 
dysfunction, the PM should be avoided if possible to prevent ischemia-reperfusion injury.
　Radiofrequency ablation （RFA）-assisted hepatectomy was first reported in 2002 13）, and 
precoagulation using such techniques could reduce intraoperative blood loss, lower transfusion 
rates, and decrease the risk of postoperative morbidity and mortality 14-16）.  Precoagulation is thus 
recommended for patients with liver cirrhosis 17，18）.  
　In this study, we investigated the feasibility of precoagulation for patients with liver cirrhosis 
undergoing endoscopic hepatectomy （EH） not involving the PM.
Patients and methods
Patients
　From January 2000 to December 2017, 150 patients underwent LH or thoracoscopic hepa-
tectomy （TH） at Showa University Hospital.  Of these, 11 patients who underwent EH for 
hepatocellular carcinoma with cirrhosis were recruited for this retrospective study.  The selected 
cases were diagnosed as stage F4 liver cirrhosis based on pathological ndings.  Table 1 lists the 
patient characteristics.
Table 1. Characteristics of patients who underwent endoscopic 
hepatectomy for hepatocellular carcinoma
Variable n＝ 11
Age in years, median （range）    61（59-76）
Male/female, n 8/3
Body mass index, mean （range） 23.1（18.1-29.5）
Comorbidities, n
　Cardiovascular disease 3
　Diabetes 4 
　Pulmonary disease 1
Child-Pugh score of A/B, n 7/4
Preoperative laboratory data, mean （range）
　Total bilirubin （mg/dl）  1.07（0.6-1.5）
　Aspartate transaminase （U/l）    48（21-98）
　Alanine transaminase （U/l）    43（17-93）
　Prothrombin time （％）    75（57-100）
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Procedure
　Preoperative image simulation was performed using the Synapse Vincent volume analyzer 
（Fujifilm Medical Co., Ltd., Tokyo, Japan）, a three-dimensional analysis system for optimal 
planning of port placement and enhanced visualization of vessels, bile ducts, and tumors.  EH 
was performed according to previously described procedures 19，20）.  The PM was not used in 
any of the patients undergoing precoagulation, but we were ready to implement it in case of 
unexpected intraoperative bleeding during the LH.  EH was performed using microwave coagula-
tion therapy （Microtase ; Alfresa Pharma, Osaka, Japan） or RFA （Habib 4X bipolar resection 
device ; AngioDynamics, Latham, NY, USA）.  Parenchymal transection was performed using an 
Ultracision Harmonic Scalpel （Ethicon, Somerville, NJ, USA） after precoagulation.  The operative 
ndings are shown in Figure 1.
Results
　RFA precoagulation was performed in seven patients, whereas microwave coagulation therapy 
was performed in four patients.  The mean operation time was 156 min （range, 80-310 min）, 
with a mean blood loss of 73 g （range, 5-200 g）.  No patients underwent the PM or required 
intraoperative transfusion, and there were no intraoperative complications or conversions to lapa-
rotomy.  All patients showed improved liver function parameters on postoperative days 1 and 5, 
although two patients developed postoperative complications comprising Clavien-Dindo grade Ⅲ 
postoperative bleeding in one case and Clavien-Dindo grade Ⅱ spontaneous bacterial peritonitis 
（SBP） in the other.  The patients’ operative characteristics and short-term outcomes are shown 
in Tables 2 and 3, respectively.
Discussion
　Minimally invasive hepatectomy is a growing eld of research, with some studies promoting 
the feasibility of LH in patients with cirrhosis 21，22）.  In the present study, EH without the PM 
was performed in 11 patients with cirrhosis after precoagulation, and only slight intraoperative 
Fig. 1.   Intraoperative findings. （a） The Habib 4X （AngioDynamics） was inserted into the cirrhotic 
liver parenchyma for coagulation and sealing of blood vessels. （b） The parenchyma was 
then divided with an Ultracision Harmonic Scalpel （Ethicon, Somerville, NJ, USA）
（a） （b）
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bleeding occurred.  This series offers valuable data regarding certain technical modications that 
prevent ischemic injury in patients with cirrhosis.
　Intraoperative bleeding makes endoscopic surgery difcult and increases the rate of conversion 
from EH to laparotomy.  Cirrhosis increases the risk of hemorrhage, and various hemostatic 
methods, techniques, and devices are needed to reduce bleeding and increase safety during EH.
　Herein, we described a method for reducing blood loss using precoagulation devices before 
parenchymal transection, although achieving parenchymal division with only slight bleeding during 
EH remains difcult in patients with cirrhosis.  Many liver surgeons perform the PM to reduce 
intraoperative bleeding ; however, the risk of bleeding remains in patients with liver cirrhosis 
because they are more susceptible to ischemia-reperfusion injury 12）.  The present study investi-
Table 3. Postoperative outcomes of patients who underwent 
endoscopic hepatectomy for hepatocellular carcinoma
Variable n＝ 11
Complications
　Postoperative bleeding, n 1
　Spontaneous bacterial peritonitis, n 1
Clavien-Dindo grade of worst complication
　None/Grade Ⅰ/Ⅱ/Ⅲ/Ⅳ/Ⅴ 9/0/1/1/0/0
Hospital stay in days, mean （range） 13.2（7-33）
Table 2. Operative outcomes of patients who underwent endoscopic hepatectomy for 
hepatocellular carcinoma
Variable n＝ 11
Technique, n
　Thoracoscopic hepatectomy 2
　Laparoscopic hepatectomy 9
Total operative time in min, mean （range）   156（80-310）
Intraoperative blood loss in g, mean （range）    73（5-200）
Conversion to open surgery, n 0
Pringle maneuver, n 0
Precoagulation by MCT/RFA, n 3/8
Intraoperative transfusion, n 0
Pathological diagnosis, n
　Hepatocellular carcinoma 11
Tumors, mean （range）   1.1（1-2）
Size of largest tumor in mm, mean （range）   27.6（7-90）
R0/R1 resection, n （％）    10（1）
Postoperative laboratory data, postop day 1/5, mean （range）
　Total bilirubin （mg/dl） 1.21（0.7-1.9）/ 1.08（0.6-1.5）
　Aspartate transaminase （U/l）   179（81-457）/   42（33-74）
　Alanine transaminase （U/l）   116（55-266）/   79（49-173）
　Prothrombin time （％）    70（63-85） /   69（56-83）
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gated the hypothesis that precoagulation and no PM is a safe alternative for reducing the risk of 
ischemia-reperfusion injury during cirrhotic parenchymal transection.
　RFA with precoagulation is one of the most commonly used techniques in the clinical treat-
ment of hepatocellular carcinoma.  Described for hepatectomy in 2002 by Weber et al 13）, RFA 
facilitates resection of the tumor itself and seals the vessels and bile ducts, promoting a nearly 
bloodless hepatectomy 23）, although a few controversial studies maintained that RFA is not 
completely safe in patients with poor hepatic functional reserve or cirrhosis 24，25）.  In response to 
the controversy, a new RFA device was developed specically for LH, the Habib 4X 14）.  Several 
studies subsequently confirmed the benefits of RFA-assisted hepatectomy for reducing blood 
loss 15，16）, and this technique was recently recommended for patients with cirrhosis 17，18）.  Some 
studies have further suggested that RFA-assisted hepatectomy without the PM can minimize the 
risk of ischemia-reperfusion injury of the remnant cirrhotic liver with only minor liver injury 17，26）. 
Additionally, laparoscopic surgery has some benefits over open surgery.  Postoperative ascites 
is the most frequent and important complication of hepatectomy, especially open hepatectomy, 
in patients with cirrhosis 27）, albeit occurring at a lower frequency than in open hepatectomy 28）. 
Mechanisms have been proposed for the reduced incidence of postoperative ascites in LH, 
including preservation of the abdominal wall collateral circulation by avoiding long abdominal 
incisions and muscle division, as well as preservation of the round ligament, which may contain 
signicant collateral veins.  Other possibilities, including less mobilization and manipulation of the 
liver during laparoscopic procedures, might reduce liver trauma 29）, limit lymphatic channel divi-
sions 30）, and lower intraoperative uid requirements.  The low liver failure rate in LH could also 
result from the same mechanisms.  Therefore, the optimal approach for patients with cirrhosis is 
safe EH with precoagulation devices and no use of the PM.
　The present study showed a mean operative time of 156 min （range, 80-310 min） and mean 
blood loss of 73 g （range, 5-200 g）.  In previous studies, the frequency of PM use reduced with 
precoagulation 14-17）, and it was not needed at all during this study.  RFA-assisted hepatectomy 
also signicantly reduces intraoperative blood loss and the rate of intraoperative blood transfu-
sions 14，15，17，18）.  In our cohort, no patients required an intraoperative blood transfusion, but one 
patient required a blood transfusion for postoperative bleeding early on the day of the operation. 
This patient showed signs of postoperative bleeding （decreasing blood pressure and hemoglobin 
concentration）, and hemorrhagic ascites was collected.  Bleeding from vessels on the resected 
surface found during the operation was ablated and a brin-coated collagen eece （Tachocomb ; 
Nycomed, Roskilde, Denmark） was applied to the resected surface during laparoscopic surgery. 
The patient’s recovery was uneventful.  The main reasons for postoperative bleeding were the 
positive pressure of a carbon dioxide pneumoperitoneum and control of the central venous 
pressure.  This procedure masks the inhibition of intraoperative bleeding compared with open 
surgery.  Patients with cirrhosis should therefore be monitored for hemostasis to reduce the pres-
sure of carbon dioxide pneumoperitoneums and raise the blood pressure before converting or 
stopping the laparoscopy.  Apart from this case, we recorded no postoperative bleeding among 
the patients undergoing LH with precoagulation.
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　As in other studies, the alanine transaminase （ALT） and aspartate transaminase （AST） levels 
were measured postoperatively to assess the extent of hepatic damage to the remnant liver. 
RFA-assisted hepatectomy patients showed signicantly higher serum ALT levels than did those 
undergoing non-RFA-assisted hepatectomy ; moreover, RFA-assisted hepatectomy can further dam-
age the cirrhotic liver 21）.  However, the AST and ALT levels quickly improved in the present 
study, and the lack of PM might have contributed to the absence of severe hepatic damage.
　One patient developed postoperative SBP.  Enterococcus faecium was detected in the collected 
ascites.  RFA-assisted hepatectomy due to necrotic remnant tissue on the surface of the resected 
area might have facilitated microbial growth leading to infection.  Our one case of SBP might 
have occurred because liver tissues subjected to coagulative necrosis are prone to infection.  In 
patients with infection secondary to ischemia-reperfusion of the liver by the PM, an increased 
warm ischemia time results in the production of a large volume of inammatory cytokines.  This 
is considered to induce injury to liver cells and hepatic sinusoidal endothelial cells, especially in 
immunosuppressed patients 11）.
　In summary, EH with precoagulation and without the PM is feasible.  Hepatectomy using pre-
coagulation could help to transect cirrhotic parenchyma with only slight intraoperative bleeding. 
Additionally, precoagulation enables EH without the PM in patients with cirrhosis and might 
help to avoid ischemic injury induced by the PM.  We propose that precoagulation may serve as 
a standard technique for EH with cirrhosis, and further studies with higher statistical power are 
warranted.
Acknowledgments
　This study was conducted without any financial support.
Conict of Interest
　All authors declare that they have no conflict of interest.
References
1） Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 
1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406.
2） Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resec-
tion of hepatocellular carcinoma. Ann Surg. 2009;249:617-623.
3） Cheung TT, Poon RT, Yuen WK, et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy 
for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg. 2013;257:506-511.
4） Kanazawa A, Tsukamoto T, Shimizu S, et al. Impact of laparoscopic liver resection for hepatocellular carcinoma 
with F4-liver cirrhosis. Surg Endosc. 2013;27:2592-2597.
5） Tranchart H, Di Giuro G, Lainas P, et al. Laparoscopic liver resection with selective prior vascular control. Am J 
Surg. 2013;205:8-14.
6） Ker CG, Chen JS, Kuo KK, et al. Liver surgery for hepatocellular carcinoma: laparoscopic versus open approach. 
Int J Hepatol. 2011;2011:596792.
415Precoagulation for Endoscopic Hepatectomy
7） Aldrighetti L, Guzzetti E, Pulitano C, et al. Case-matched analysis of totally laparoscopic versus open liver resec-
tion for HCC: short and middle term results. J Surg Oncol. 2010;102:82-86.
8） Tranchart H, Di Giuro G, Lainas P, et al. Laparoscopic resection for hepatocellular carcinoma: a matched-pair 
comparative study. Surg Endosc. 2010;24:1170-1176.
9） Belli G, Ciof L, Fantini C, et al. Laparoscopic redo surgery for recurrent hepatocellular carcinoma in cirrhotic 
patients: feasibility, safety, and results. Surg Endosc. 2009;23:1807-1811.
10） Croome KP, Yamashita MH. Laparoscopic vs open hepatic resection for benign and malignant tumors: an updated 
meta-analysis. Arch Surg. 2010;145:1109-1118.
11） Meguro M, Katsuramaki T, Kimura H, et al. Apoptosis and necrosis after warm ischemia-reperfusion injury of the 
pig liver and their inhibition by ONO-1714. Transplantation. 2003;75:703-710.
12） Camacho VR, de Fraga RS, Cerski CT, et al. Relationship between ischemia/reperfusion injury and the stimulus 
of fibrogenesis in an experimental model: comparison among different preservation solutions. Transplant Proc. 
2011;43:3634-3637.
13） Weber JC, Navarra G, Jiao LR, et al. New technique for liver resection using heat coagulative necrosis. Ann Surg. 
2002;236:560-563.
14） Pai M, Jiao LR, Khorsandi S, et al. Liver resection with bipolar radiofrequency device: Habib 4X. HPB. 
2008;10:256-260.
15） Pai M, Frampton AE, Mikhail S, et al. Radiofrequency assisted liver resection: analysis of 604 consecutive cases. 
Eur J Surg Oncol. 2012;38:274-280.
16） Daylami R, Kargozaran H, Khatri VP. Liver resection using bipolar InLine multichannel radiofrequency device: 
impact on intra- and peri-operative outcomes. Eur J Surg Oncol. 2012;38:531-536.
17） Li M, Zhang W, Li Y, et al. Radiofrequency-assisted versus clamp-crushing parenchyma transection in cirrhotic 
patients with hepatocellular carcinoma: a randomized clinical trial. Dig Dis Sci. 2013;58:835-840.
18） Curro G, Jiao L, Scisca C, et al. Radiofrequency-assisted liver resection in cirrhotic patients with hepatocellular 
carcinoma. J Surg Oncol. 2008;98:407-410.
19） Murakami M, Aoki T, Kato T. Video-assisted thoracoscopic surgery: hepatectomy for liver neoplasm. World J Surg. 
2011;35:1050-1054.
20） Aoki T, Murakami M, Koizumi T, et al. Three-dimensional virtual endoscopy for laparoscopic and thoracoscopic 
liver resection. J Am Coll Surg. 2015;221:e21-e26.
21） Zhang F, Yan J, Feng XB, et al. Efciency and safety of radiofrequency-assisted hepatectomy for hepatocellular 
carcinoma with cirrhosis: a single-center retrospective cohort study. World J Gastroenterol. 2015;21:10159-10165.
22） Worhunsky DJ, Dua MM, Tran TB, et al. Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. 
Surg Endosc. 2016;30:4307-4314.
23） Delis SG, Madariaga J, Bakoyiannis A, et al. Current role of bloodless liver resection. World J Gastroenterol. 
2007;13:826-829.
24） Mitsuo M, Takahiro T, Yasuko T, et al. Radiofrequency （RF）-assisted hepatectomy may induce severe postopera-
tive liver damage. World J Surg. 2007;31:2208-2212.
25） Lupo L, Gallerani A, Panzera P, et al. Randomized clinical trial of radiofrequency-assisted versus clamp-crushing 
liver resection. Br J Surg. 2007;94:287-291.
26） Galun DA, Bulajic P, Zuvela M, et al. Is there any benet from expanding the criteria for the resection of hepa-
tocellular carcinoma in cirrhotic liver? Experience from a developing country. World J Surg. 2012;36:1657-1665.
27） Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic 
value of preoperative portal pressure. Gastroenterology. 1996;111:1018-1022.
28） Cai XJ, Yang J, Yu H, et al. Clinical study of laparoscopic versus open hepatectomy for malignant liver tumors. 
Surg Endosc. 2008;22:2350-2356.
Yoshihiko TASHIRO, et al416
29） Schemmer P, Schoonhoven R, Swenberg JA, et al. Gentle in situ liver manipulation during organ harvest decreases 
survival after rat liver transplantation: role of Kupffer cells. Transplantation. 1998;65:1015-1020.
30） Arroyo V, Gines P, Planas R. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume 
paracentesis. Gastroenterol Clin North Am. 1992;21:237-256.
［Received May 7, 2018 : Accepted August 9, 2018］ 
